Cargando…
Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a malignancy with high heterogeneity in its biological features and treatments. Although the overall survival (OS) of patients with ALL has recently improved considerably, owing to the application of conventional chemo-therapeutic agents, approximately 20% of th...
Autores principales: | Jiménez-Morales, Silvia, Aranda-Uribe, Ivan Sammir, Pérez-Amado, Carlos Jhovani, Ramírez-Bello, Julian, Hidalgo-Miranda, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636671/ https://www.ncbi.nlm.nih.gov/pubmed/34867958 http://dx.doi.org/10.3389/fimmu.2021.737340 |
Ejemplares similares
-
MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia
por: Mendiola-Soto, Diana Karen, et al.
Publicado: (2023) -
Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression
por: Pérez-Amado, Carlos Jhovani, et al.
Publicado: (2021) -
Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
por: Pastorczak, Agata, et al.
Publicado: (2021) -
Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia
por: Bárcenas-López, Diego Alberto, et al.
Publicado: (2020) -
Long Non-Coding RNA and Acute Leukemia
por: Cruz-Miranda, Gabriela Marisol, et al.
Publicado: (2019)